| Aurobindo Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 58.08 | 58.59 | 58.59 | 58.59 | 58.59 |
| Reserves | 20,476.03 | 19,664.23 | 17,855.58 | 17,058.75 | 15,866.02 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 20,534.11 | 19,722.82 | 17,914.17 | 17,117.34 | 15,924.61 |
| Secured Loans | 1,842.41 | 1,431.99 | 1,922.78 | 288.75 | 841.50 |
| Unsecured Loans | 2,804.19 | 1,428.75 | 2,280.38 | 1,606.14 | 3,186.02 |
| Total Debt | 4,646.60 | 2,860.74 | 4,203.16 | 1,894.89 | 4,027.52 |
| Other Liabilities | 53.30 | 46.00 | 87.31 | 5.03 | 0.00 |
| Total Liabilities | 25,234.01 | 22,629.56 | 22,204.64 | 19,017.26 | 19,952.13 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 4,230.61 | 4,043.49 | 6,214.70 | 5,724.90 | 6,820.35 |
| Less: Accumulated Depreciation | 1,893.81 | 1,624.36 | 2,527.20 | 2,139.07 | 2,348.28 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 2,336.80 | 2,419.13 | 3,687.50 | 3,585.83 | 4,472.07 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 87.53 | 132.68 | 239.09 | 225.15 | 734.89 |
| Investments | 15,209.57 | 13,393.44 | 8,221.78 | 6,584.36 | 5,009.93 |
| Current Assets, Loans & Advances | |||||
| Inventories | 2,359.28 | 2,367.60 | 4,125.26 | 3,356.18 | 4,841.38 |
| Sundry Debtors | 4,195.05 | 3,776.59 | 4,560.26 | 3,973.24 | 5,928.01 |
| Cash and Bank Balance | 298.36 | 94.34 | 132.14 | 50.78 | 386.18 |
| Loans and Advances | 836.70 | 1,000.59 | 905.97 | 2,454.90 | 1,093.25 |
| Total Current Assets | 7,689.39 | 7,239.12 | 9,723.63 | 9,835.10 | 12,248.82 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 2,092.61 | 2,285.86 | 2,391.01 | 2,243.30 | 2,553.47 |
| Provisions | 85.01 | 119.65 | 122.09 | 103.36 | 250.01 |
| Total CL & Provisions | 2,177.62 | 2,405.51 | 2,513.10 | 2,346.66 | 2,803.48 |
| Net Current Assets | 5,511.77 | 4,833.61 | 7,210.53 | 7,488.44 | 9,445.34 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 51.87 | 47.45 | 55.24 | 43.82 | 68.61 |
| Deferred Tax Liability | 153.30 | 166.36 | 271.15 | 280.85 | 501.99 |
| Net Deferred Tax | -101.43 | -118.91 | -215.91 | -237.03 | -433.38 |
| Other Assets | 2,189.77 | 1,969.61 | 3,061.65 | 1,370.51 | 723.28 |
| Total Assets | 25,234.01 | 22,629.56 | 22,204.64 | 19,017.26 | 19,952.13 |
| Contingent Liabilities | 220.81 | 1,969.15 | 120.26 | 152.93 | 887.66 |